Historic Marijuana Reclassification: Changes & Implications

Posted on June 29, 2026

Date/Time: 06/29/2026, 12:00 am

Provider: FHPCA

Map Unavailable

Historic Marijuana Reclassification: Changes & Implications

Marijuana just moved off Schedule 1, but the risk didn’t disappear.

It just got more complicated. Get clear on what actually changed, what didn’t, and what your agency needs to do next before the regulators do it for you.

KEY WEBINAR TAKEAWAYS

How historic marijuana rescheduling does — and does not — impact hospice and home care company employees, patients, and business processes
Current legal status of medical marijuana in light of historic rescheduling
How reclassification affects your marijuana policy and procedures

BONUS MATERIALS

Whitepaper: Marijuana Policy & Best Practices: Handling Employee Medical & Recreational Use
Marijuana Rules: Guidelines for Creating Effective Cannabis Policy & Procedures

WEBINAR DETAILS

In April 2026, the long-awaited reclassification of marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol® with codeine) was announced by the Department of Justice. The historic rescheduling of medical marijuana will favorably impact the cannabis industry — and potentially could impact hospices and home care companies. This webinar will discuss what marijuana reclassification does (and does not) mean for the healthcare industry. Learn what this rescheduling means (or does not mean) for your organization’s marijuana policy, people, patients, testing program, terminations, accommodations, and other HR, HIPAA, and business issues.

THIS WEBINAR WILL BENEFIT THE FOLLOWING AGENCIES:

Hospice
Home Care
Home Health
Palliative Care

WHO SHOULD ATTEND?

Compliance
HR
Training
Legal
Managers and executives
Anyone responsible for workplace policy and compliance

TAKE-AWAY TOOLKIT

Employee training log
Interactive quiz
PDF of slides and speaker’s contact info for follow-up questions
Attendance certificate provided to self-report CE credits

NOTE: All materials are subject to copyright. Transmission, retransmission, or republishing of any webinar to other institutions or those not employed by your institution is prohibited. Print materials may be copied for eligible participants only.